The Global Challenge of Antimicrobial Resistance: Insights from Economic Analysis
Open Access
- 9 August 2010
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 7 (8), 3141-3149
- https://doi.org/10.3390/ijerph7083141
Abstract
The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention. Like an environmental resource, antimicrobials require stewardship. The effectiveness of an antimicrobial agent is a global public good. We argue for greater use of economic analysis as an input to policy discussion about AR, including for understanding the incentives underlying health behaviors that spawn AR, and to supplement other methods of tracing the evolution of AR internationally. We also discuss integrating antimicrobial stewardship into global health governance.The prevalence of antimicrobial resistance (AR) limits the therapeutic options for treatment of infections, and increases the social benefit from disease prevention. Like an environmental resource, antimicrobials require stewardship. The effectiveness of an antimicrobial agent is a global public good. We argue for greater use of economic analysis as an input to policy discussion about AR, including for understanding the incentives underlying health behaviors that spawn AR, and to supplement other methods of tracing the evolution of AR internationally. We also discuss integrating antimicrobial stewardship into global health governance.Keywords
This publication has 23 references indexed in Scilit:
- Antimicrobial resistance prevention initiative—an update: Proceedings of an expert panel on resistanceAmerican Journal of Infection Control, 2007
- Worldwide Emergence of Extensively Drug-resistant TuberculosisEmerging Infectious Diseases, 2007
- Will A Global Subsidy Of New Antimalarials Delay The Emergence Of Resistance And Save Lives?Health Affairs, 2006
- The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care CostsClinical Infectious Diseases, 2006
- Antimicrobial Resistance Determinants and Future ControlEmerging Infectious Diseases, 2005
- Identifying Antimicrobial Resistance Genes with DNA MicroarraysAntimicrobial Agents and Chemotherapy, 2003
- Environmental Problems and Policy: 2000–2050Journal of Economic Perspectives, 2000
- Doing It Now or LaterAmerican Economic Review, 1999
- Golden Eggs and Hyperbolic DiscountingThe Quarterly Journal of Economics, 1997
- Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial EraScience, 1992